Since the start of the COVID-19 (coronavirus disease 2019) pandemic in late December 2019, the etiological agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of
Read more
Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral remdesivir, its potency increases significantly,
Read more
The global spread of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to intense interest
Read more
The rapid spread of severe acute respiratory syndrome virus-2 (SARS-CoV-2) across the world has led to the rapid development of diagnostic kits that are highly
Read more
Each of the three approved vaccines against coronavirus disease 2019 (COVID-19) – Moderna, BioNTech-Pfizer and Oxford-Astrazeneca – generate forms of the spike protein of severe
Read more
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), are being administered worldwide. A successful, safe and
Read more
Researchers in the UK have shown that the increased transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.7 that emerged in the
Read more
Researchers in Italy have conducted a study showing that patients who had tested positive for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still
Read more
Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, coronavirus disease 2019 (COVID-19) is speculated to be involved in various pulmonary and cardiometabolic conditions.
Read more
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), resides in mucous membranes, making it easy to detect viral
Read more